pH Pharma Co., Ltd.
6Patents
6Active
6Granted
43Portfolio score
Filing activity: Mar 15, 2016 → Sep 11, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10316001B2 | Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrohydro pyrimidine-5-carbonitrile | Chemistry; Metallurgy | 1 | Active |
| US10301319B2 | Thailanstatin analogs | Chemistry; Metallurgy | 0 | Active |
| US10676443B2 | Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrile | Chemistry; Metallurgy | 0 | Active |
| US10815246B2 | Thailanstatin analogs | Chemistry; Metallurgy | 0 | Active |
| US10806735B2 | Use of neutrophil elastase inhibitors in liver disease | Human Necessities | 0 | Active |
| US11691982B2 | Thailanstatin analogs | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.